![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ActivX Biosciences Announces Closing of Acquisition by Kyorin
ActivX Biosciences Announces Closing of Acquisition by Kyorin
ActivX Biosciences, a biotechnology company developing advanced proteomic technologies
for drug discovery and development, has announced the formal completion of its
acquisition by Tokyo-based Kyorin Pharmaceutical. The acquisition agreement
was signed on Dec. 1, 2004, for an aggregate price of $21,000,000. With the
completion of the transaction, ActivX survives as a wholly owned subsidiary
and will serve as Kyorin's drug discovery and development center in the U.S.
Yahoo
News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct